Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of January 5, 2025 • 6:00 PM ET

Date/Time Source News Release
12/19/2024 07:05 AM EST GlobeNewswire Clearside Biomedical Announces Publication of Critical Insights into Retinal Drug Development in the Peer-Reviewed Scientific Journal, Eye
11/25/2024 07:05 AM EST GlobeNewswire Clearside Biomedical Extends Global Footprint with Numerous Presentations at Medical Meetings in Asia, Europe and the United States
11/12/2024 04:05 PM EST GlobeNewswire Clearside Biomedical Announces Third Quarter 2024 Financial Results and Provides Corporate Update
11/07/2024 09:05 AM EST GlobeNewswire Clearside Biomedical Partner Arctic Vision Executes Commercial Collaboration Agreement with Santen Pharmaceutical Co., Ltd for ARVN001 Suprachoroidal Space Injection Therapy for the Treatment of Uveitic Macular Edema
11/06/2024 07:05 AM EST GlobeNewswire Clearside Biomedical to Participate in Fireside Chat at the Stifel 2024 Healthcare Conference
11/04/2024 07:05 AM EST GlobeNewswire Clearside Biomedical Appoints Tony Gibney as New Chair of the Board of Directors
10/31/2024 07:05 AM EDT GlobeNewswire Clearside Biomedical to Report Third Quarter 2024 Financial Results and Provide Corporate Update on Tuesday, November 12, 2024
10/22/2024 07:05 AM EDT GlobeNewswire Clearside Biomedical's Positive ODYSSEY Wet AMD Data and Suprachoroidal Injection Platform Highlighted in Presentations at Multiple Events During AAO 2024 Annual Meeting
10/09/2024 06:30 AM EDT GlobeNewswire Clearside Biomedical Announces Positive Topline Results from ODYSSEY Phase 2b Trial of Suprachoroidal CLS-AX in Wet AMD Achieving All Primary and Secondary Outcomes
08/27/2024 07:05 AM EDT GlobeNewswire Clearside Biomedical Announces Completion of Final Participant Visit in ODYSSEY Phase 2b Trial of CLS-AX in Wet AMD
Page

Additional News

As of January 5, 2025 • 6:00 PM ET

Date/Time Source News Release
12/12/2024 09:55 AM EST Zacks Here's Why Clearside Biomedical (CLSD) Is a Great 'Buy the Bottom' Stock Now
11/15/2024 12:00 PM EST Zacks All You Need to Know About Clearside Biomedical (CLSD) Rating Upgrade to Buy
11/14/2024 04:37 AM EST US Earnings Reports Expected earnings - Clearside Biomedical Inc.
11/12/2024 08:37 PM EST SeekingAlpha Clearside Biomedical, Inc. (CLSD) Q3 2024 Earnings Conference Call Transcript
11/12/2024 06:05 PM EST Zacks Clearside Biomedical, Inc. (CLSD) Reports Q3 Loss, Tops Revenue Estimates
11/12/2024 04:36 PM EST SeekingAlpha Clearside Biomedical GAAP EPS of -$0.10 beats by $0.02, revenue of $1.03M beats by $0.91M
11/12/2024 01:00 AM EST SeekingAlpha Here are the major earnings after the close today
11/06/2024 05:30 PM EST Zacks Celldex Therapeutics (CLDX) Reports Q3 Loss, Tops Revenue Estimates
10/09/2024 04:22 PM EDT SeekingAlpha Clearside stock falls 12% amid Phase 2 data for CLS-AX
08/27/2024 09:57 AM EDT Baystreet Clearside Slips on Trials
Page